Citation Indices
|
All
|
Since 2019
|
Citation
|
231
|
195
|
h-index
|
7
|
6
|
i10-index
|
3
|
3
|
Acceptance Rate (By Year)
|
|
Year
|
Percentage
|
2023
|
10.84%
|
2022
|
9.14%
|
2021
|
11.26%
|
2020
|
11.8%
|
2019
|
10.3%
|
2018
|
8.65%
|
2017
|
12.9%
|
2016
|
10.9%
|
2015
|
12.5%
|
DOI: 10.25125/medical-journal
IMJ Health: A Member of CrossRef USA
WorldCat, Tyndale University Publons, Indiana University, Index Copernicus
Editor-in-Chief: Dr. Kusum Gaur
ISSN: 2395-6291
Frequency: Monthly (12 issues per year)
DOI: 10.25125/medical-journal
Submit Article Online: Click here to Submit
Send Article to E-mail: info@imjhealth.org or info.imjh@gmail.com
Guidelines to Authors: Click here to get Details
Language of Publication: English
Nature: Refereed/Peer-Reviewed Engineering Journal
Year of Commencement: 2015
Brazil is recognized as one of the leading nations in Latin America for medical and pharmaceutical research. With a robust network of research institutions and universities, the country plays a critical role in global health research, particularly in areas related to tropical medicine and infectious diseases. Brazil's vast biodiversity also contributes to its potential in pharmaceutical research, especially in drug discovery.
Medical Journal: IMJ Health is a prestigious international journal committed to the rapid publication of high-quality original research in the fields of medical and pharmaceutical sciences. As a broad-based, open-access journal, IMJ Health welcomes groundbreaking research from across the globe. We are proud to be indexed and abstracted by major global databases, ensuring wide visibility and recognition for our authors.
At IMJ Health, we are dedicated to fostering a future where research is valued for its creativity, quality, and impact. Our mission is to motivate and guide researchers towards achieving a vision of "Total Egalitarian Research" while maintaining open communication with our editorial board and contributors.
Brazil's medical and pharmaceutical research encompasses a wide range of fields including public health, epidemiology, and vaccine development. Brazil has made significant contributions to research on diseases such as Zika, dengue, and yellow fever. Additionally, the pharmaceutical sector in Brazil is focused on innovation in biotechnology and the development of new therapies, leveraging the country’s unique natural resources.
Our journal is peer-reviewed, guaranteeing the quality and reliability of the research published within its pages. By publishing in IMJ Health, authors contribute to a valuable resource for medical professionals, researchers, and students worldwide.
By contributing to the medical and pharmaceutical research landscape, you are joining a global network of researchers dedicated to advancing health outcomes. IMJ Health invites professionals, academics, and institutions to share their innovative findings, collaborate on groundbreaking studies, and be part of a collective effort to improve healthcare worldwide. Together, we can address the challenges and opportunities in medical science and inspire the next generation of researchers.